IQVIA Holdings target price raised to $329 from $300
IQV•Truist Securities raised its target price for IQVIA Holdings to $329 from $300.
Related News
Silexion says SIL204 uses native serum lipids for cellular uptake, boosts KRAS knockdown in preclinical study
SLXN•
Lifecore Biomedical agrees to be acquired by Webster Equity Partners for $6.28 a share plus CVR
LFCR•
Gerdau executives join panels at Congresso Aço Brasil 2026 steel industry conference
GGB•
Achieve Life Sciences to present 52-week cytisinicline data at CHEST 2026
ACHV•
Truist Wealth names Caroline Murtaugh regional managing director for Georgia
TFC•